XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The following table sets forth the fair value of the Company’s financial assets and liabilities measured on a recurring basis by level within the fair value hierarchy (in thousands):
March 31, 2022
Level ILevel IILevel IIITotal
Financial Assets
Money market funds$53,874 $— $— $53,874 
Certificates of deposit— 4,605 — 4,605 
Cash equivalents53,874 4,605 — 58,479 
Commercial paper— 55,283 — 55,283 
U.S. Treasury and government debt securities— 44,975 — 44,975 
Marketable securities— 100,258 — 100,258 
Equity investment7,320 — — 7,320 
Non-current assets7,320 — — 7,320 
Total Financial Assets$61,194 $104,863 $— $166,057 
December 31, 2021
Level ILevel IILevel IIITotal
Financial Assets
Money market funds$65,311 $— $— $65,311 
Certificates of deposit— 5,942 — 5,942 
Cash equivalents65,311 5,942 — 71,253 
Commercial paper— 50,954 — 50,954 
U.S. Treasury and government debt securities— 26,167 — 26,167 
Marketable securities— 77,121 — 77,121 
Equity investment5,948 — — 5,948 
Non-current assets5,948 — — 5,948 
Total Financial Assets$71,259 $83,063 $— $154,322 

The Company’s financial assets consist of Level I and II assets. The Company had no Level III assets or liabilities for the periods presented. The Company classifies its cash equivalents and marketable securities within Level I or Level II because they are valued using either quoted market prices or inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. The Company’s fixed income available-for-sale securities consist of high quality, investment grade securities from diverse issuers. The valuation techniques used to measure the fair value of the Company’s marketable securities were derived from non-binding market consensus prices that are corroborated by observable market data and quoted market prices for similar instruments.